Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies
- PMID: 36914790
- PMCID: PMC10010657
- DOI: 10.1038/s41584-023-00932-6
Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies
Abstract
In primary Sjögren syndrome (pSS), chronic inflammation of exocrine glands results in tissue destruction and sicca symptoms, primarily of the mouth and eyes. Fatigue, arthralgia and myalgia are also common symptoms, whereas extraglandular manifestations that involve the respiratory, nervous and vascular systems occur in a subset of patients. The disease predominantly affects women, with an estimated female to male ratio of 14 to 1. The aetiology of pSS, however, remains incompletely understood, and effective treatment is lacking. Large-scale genetic and epigenetic investigations have revealed associations between pSS and genes in both innate and adaptive immune pathways. The genetic variants mediate context-dependent effects, and both sex and environmental factors can influence the outcome. As such, genetic and epigenetic studies can provide insight into the dysregulated molecular mechanisms, which in turn might reveal new therapeutic possibilities. This Review discusses the genetic and epigenetic features that have been robustly connected with pSS, putting them into the context of cellular function, carrier sex and environmental challenges. In all, the observations point to several novel opportunities for early detection, treatment development and the pathway towards personalized medicine.
© 2023. Springer Nature Limited.
Conflict of interest statement
M.W.-H. has received research grants from Merck KGaA and Janssen Pharmaceutica NV during the past 5 years. G.E.T. and A.B. declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10010657/bin/41584_2023_932_Fig6_HTML.gif)
Similar articles
-
One year in review 2020: pathogenesis of primary Sjögren's syndrome.Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):3-9. Epub 2020 Sep 29. Clin Exp Rheumatol. 2020. PMID: 33025887 Review.
-
Epigenetic alterations in primary Sjögren's syndrome - an overview.Clin Immunol. 2018 Nov;196:12-20. doi: 10.1016/j.clim.2018.04.004. Epub 2018 Apr 9. Clin Immunol. 2018. PMID: 29649576 Review.
-
Primary Sjögren's syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy.Expert Opin Pharmacother. 2001 Sep;2(9):1415-36. doi: 10.1517/14656566.2.9.1415. Expert Opin Pharmacother. 2001. PMID: 11585021 Review.
-
[Sjögren's Syndrome: Early diagnosis and effective treatment].Dtsch Med Wochenschr. 2018 Dec;143(24):1778-1782. doi: 10.1055/a-0547-1025. Epub 2018 Dec 3. Dtsch Med Wochenschr. 2018. PMID: 30508859 German.
-
Advances in the diagnosis and treatment of Sjogren's syndrome.Clin Rheumatol. 2018 Jul;37(7):1743-1749. doi: 10.1007/s10067-018-4153-8. Epub 2018 May 26. Clin Rheumatol. 2018. PMID: 29804149 Review.
Cited by
-
Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases.Clin Rev Allergy Immunol. 2024 Aug 29. doi: 10.1007/s12016-024-09003-4. Online ahead of print. Clin Rev Allergy Immunol. 2024. PMID: 39207646 Review.
-
Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases.ACS Nano. 2024 Aug 27;18(34):22793-22828. doi: 10.1021/acsnano.4c08486. Epub 2024 Aug 14. ACS Nano. 2024. PMID: 39141830 Free PMC article. Review.
-
Exploring the crosstalk molecular mechanisms between IgA nephropathy and Sjögren's syndrome based on comprehensive bioinformatics and immunohistochemical analyses.Clin Exp Med. 2024 Aug 13;24(1):188. doi: 10.1007/s10238-024-01420-1. Clin Exp Med. 2024. PMID: 39136821 Free PMC article.
-
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.bioRxiv [Preprint]. 2023 Oct 6:2023.10.05.561076. doi: 10.1101/2023.10.05.561076. bioRxiv. 2023. PMID: 39071447 Free PMC article. Preprint.
-
Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sjögren's syndrome coexisting with NMOSD: a case report and literature review.Front Immunol. 2024 Jul 11;15:1429405. doi: 10.3389/fimmu.2024.1429405. eCollection 2024. Front Immunol. 2024. PMID: 39055718 Free PMC article. Review.
References
-
- Shiboski CH, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 2017;76:9–16. doi: 10.1136/annrheumdis-2016-210571. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials